Gerhard Zugmaier, MD Discusses Acute Lymphoblastic Leukemia
Gerhard Zugmaier, MD
At the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Rare Disease Report sat down with Gerhard Zugmaier, MD of Amgen and the University of Marburg to discuss acute lymphoblastic leukemia, how it's diagnosed, and why it's considered a rare disease, despite its commonality in children.
Among the questions asked were:
How is acute lymphoblastic leukemia (ALL) diagnosed? (0:01)
If ALL is a common malignancy in children, why is it considered a rare disease? (0:20)